Aclaris Therapeutics, Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2019 to Q4 2023.
  • Aclaris Therapeutics, Inc. Amortization of Intangible Assets for the quarter ending December 31, 2023 was $18K, unchanged year-over-year.
  • Aclaris Therapeutics, Inc. Amortization of Intangible Assets for the twelve months ending December 31, 2023 was $75K, unchanged year-over-year.
  • Aclaris Therapeutics, Inc. annual Amortization of Intangible Assets for 2023 was $75K, unchanged from 2022.
  • Aclaris Therapeutics, Inc. annual Amortization of Intangible Assets for 2022 was $75K, unchanged from 2021.
  • Aclaris Therapeutics, Inc. annual Amortization of Intangible Assets for 2021 was $75K, unchanged from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $75K $18K $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $75K $19K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $75K $19K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $75K $19K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $75K $18K $0 0% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $75K $19K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $75K $19K $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $75K $19K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $75K $18K Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $19K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $19K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $19K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q2 2019 $1.66M Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.66M Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.